Cubist Systematic Strategies’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26,493
Closed -$52.7K 3229
2025
Q2
$52.7K Buy
+26,493
New +$48.5K ﹤0.01% 2780
2023
Q2
Sell
-203
Closed -$3.36K 3861
2023
Q1
$3.36K Buy
+203
New +$3.25K ﹤0.01% 3768
2022
Q3
Sell
-800
Closed -$9K 4548
2022
Q2
$9K Buy
+800
New +$9.5K ﹤0.01% 4275

Cubist Systematic Strategies's HLVX Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 26,493 shares — an estimated $52.7K sold.

Cubist Systematic Strategies first reported a position in HLVX in Q2 2022 and held it in 3 quarters. The position peaked at $52.7K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 26,493 HilleVax shares in Q3 2025, an estimated $52.7K.
  • Cubist Systematic Strategies first reported a position in HilleVax in Q2 2022 and held it in 3 quarters.
  • Cubist Systematic Strategies's HilleVax position peaked at $52.7K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.